Retail & Wholesale » Retail | COSMOS Pharmaceutical Corp.

COSMOS Pharmaceutical Corp. | Balance Sheet

Fiscal year is June-May. All values JPY Millions.
2014
2015
2016
2017
2018
Cash & Short Term Investments
21,302
18,635
27,282
27,728
21,668
Total Accounts Receivable
2,346
2,739
2,986
3,387
4,627
Inventories
31,261
34,863
38,227
40,038
48,749
Other Current Assets
2,188
2,185
2,410
2,592
3,026
Total Current Assets
57,097
58,422
70,905
73,749
78,073
Net Property, Plant & Equipment
69,147
93,772
114,463
134,450
153,976
Total Investments and Advances
14,116
14,608
15,193
15,413
3,826
Intangible Assets
679
489
332
215
295
Other Assets
1,258
1,409
1,499
1,597
14,014
Total Assets
142,700
168,918
202,595
225,691
250,609
ST Debt & Current Portion LT Debt
2,247
5,395
6,569
6,270
5,029
Accounts Payable
66,844
70,773
82,472
91,735
105,062
Income Tax Payable
4,426
3,982
4,682
4,116
4,239
Other Current Liabilities
7,845
9,474
9,734
12,011
12,106
Total Current Liabilities
81,362
89,624
103,457
114,132
126,436
Long-Term Debt
4,390
11,734
20,099
15,504
12,172
Provision for Risks & Charges
1,939
1,905
2,082
2,196
2,387
Deferred Taxes
403
218
203
264
420
Other Liabilities
610
600
778
804
723
Total Liabilities
88,301
103,863
126,416
132,636
141,718
Common Equity (Total)
54,399
65,055
76,179
93,053
108,888
Total Shareholders' Equity
54,399
65,055
76,179
93,053
108,888
Total Equity
54,399
65,055
76,179
93,053
108,888
Liabilities & Shareholders' Equity
142,700
168,918
202,595
225,689
250,606

About COSMOS Pharmaceutical

View Profile
Address
Daiichi Fukuoka Building S-Wing, 4/F
Fukuoka Fukuoka 812
Japan
Employees -
Website http://www.cosmospc.co.jp
Updated 07/08/2019
COSMOS Pharmaceutical Corp. engages in the operation of drugstores. It operates through the following business divisions: Pharmaceutical, Cosmetics, Miscellaneous Goods, General Food, and Others. The Pharmaceutical division markets general drugs, health drinks, oral and nursing care products, vitamins, health food, and dietary food and supplements.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.